Switch to:
PDL BioPharma Inc (NAS:PDLI)
Net Issuance of Debt
$-77.7 Mil (TTM As of Mar. 2016)

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. PDL BioPharma Inc's net issuance of debt for the three months ended in Mar. 2016 was $-25.0 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2016 was $-77.7 Mil.


Definition

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

PDL BioPharma Inc Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2016 was -180.05 (Jun. 2015 ) + -25 (Sep. 2015 ) + 152.387 (Dec. 2015 ) + -25 (Mar. 2016 ) = $-77.7 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Cash from Financing


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

PDL BioPharma Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Net Issuance of Debt -0.7-7.4-0.7215.8-121.9-95.0-93.474.2225.025.0

PDL BioPharma Inc Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
Net Issuance of Debt 0.0251.3-18.8-18.811.277.7-180.1-25.0152.4-25.0
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK